DA Davidson Upgrades PaySign to Buy
DA Davidson analyst Peter Heckmann upgrades PaySign (NASDAQ:PAYS) from Neutral to Buy.
Ladenburg Thalmann Upgrades PaySign to Buy, Raises Price Target to $3.75
Ladenburg Thalmann analyst Jon Hickman upgrades PaySign (NASDAQ:PAYS) from Neutral to Buy and raises the price target from $3.5 to $3.75.
PaySign: Q2 Earnings Insights
Shares of PaySign (NASDAQ:PAYS) rose in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share fell 0.00% year over year to ($0.02), which missed the estimate of ($0.01).
PaySign Q2 EPS $(0.02) Misses $(0.01) Estimate, Sales $6.70M Miss $6.82M Estimate
PaySign (NASDAQ:PAYS) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $(0.01) by 100 percent. The company reported quarterly sales of $6.70 million which missed the analyst
Earnings Scheduled For August 10, 2021
Companies Reporting Before The Bell
• Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter.
Earnings Outlook For PaySign
PaySign (NASDAQ:PAYS) announces its next round of earnings this Tuesday, August 10. Here is Benzinga's look at PaySign's Q2 earnings report.
Stocks That Hit 52-Week Lows On Thursday
During Thursday's morning session, 77 companies made new 52-week lows.